Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy

Purpose of the study?

Determine whether sensorimotor training (SMT) and whole-body vibration (WBV) reduce the onset and symptoms of chemotherapy-induced peripheral neuropathy (CIPN).

Why was the study conducted?

CIPN is common, reduces function and quality of life, and may force chemotherapy dose reduction, delay, or discontinuation.

What was the main research question?

Can neuromuscular training prevent CIPN in patients receiving oxaliplatin or vinca alkaloids?

Main conclusion?

SMT and WBV reduced CIPN onset by about 50%–70% compared with usual care.

Which intervention was most effective?

Sensorimotor training.

What additional benefits occurred with SMT?

Better balance, vibration sense, touch sensation, lower-leg strength, less pain and burning, fewer chemotherapy dose reductions, and lower mortality.

What benefit occurred with WBV?

Reduced CIPN incidence and improved bipedal balance.

Which chemotherapy group benefited most?

Patients receiving vinca alkaloids, especially when combined with SMT.

What was the clinical significance of reducing CIPN?

Patients may maintain function, quality of life, and chemotherapy tolerance.

Main PT implication?

Begin supervised neuromuscular training during neurotoxic chemotherapy rather than waiting for neuropathy to develop.

How could SMT be used clinically?

Use progressive balance exercises on increasingly unstable surfaces, twice weekly, individualized to the patient.

How could WBV be used clinically?

Use supervised vibration training, especially for patients who are less mobile or unable to tolerate more active balance training.

Why is SMT practical for oncology rehabilitation?

It is low cost, low intensity, standardized, feasible, and had no intervention-related adverse events.

Can the findings be generalized to all patients receiving chemotherapy?

Not fully; the study specifically included patients receiving oxaliplatin or vinca alkaloids.

What is the key exam takeaway?

Preventive neuromuscular training—especially SMT—substantially reduced CIPN and improved neurologic and clinical outcomes during chemotherapy.